doi: 10.1111/j.1742-481X.2012.01022.x 182 WolakMStaszewskaTJuszczakMGadyszyskaMBojanowskaE
Generally, a multidisciplinary team conducts FIH trials, including a clinical pharmacologist, a safety physician, a formulation scientist, a clinical development scientist, a clinical operation specialist, a toxicologist, and a regulatory affair specialist
He then brushed off concerns about CagriSemas marketability, as it has already been submitted to the FDA based on previous late-stage tests for weight management
They also followed up after sessions, which showed genuine care for their clients
From a regulatory standpoint, MOTS-c is classified as a research peptide in most jurisdictions and is not FDA-approved for any indication
If FDA adds any of the peptides to the 503A Bulks List, eligible compounding pharmacies could prepare them for individual patients with valid prescriptions